One of America’s Fastest-Growing Lobbying Firms - Ranked by Bloomberg

Health Policy Report (9/9)

The Week Ahead

Congress is set to return to action today as lawmakers gear up for a high-profile legislative blitz to close out 2019. Government funding will be a top priority for legislators when both chambers gavel in as the Sept. 30 funding deadline looms. While the Senate Appropriations Committee plans to begin marking up measures next Thursday — tackling bills for Defense, Labor-HHS-Education, Energy-Water and State-Operations — it's likely that both chambers will need to pass a continuing resolution (CR) to extend funding beyond the Sept. 30 deadline, allowing negotiators to hammer out broader agreement that averts another potential government shutdown. House Majority Leader Steny Hoyer (D-MD) stated late last week that the House will vote on a stopgap funding bill during the week of Sept. 16.

Continue reading “Health Policy Report (9/9)”

Health Policy Report (9/3)

Johnson & Johnson Ordered to Pay for Role in Opioid Epidemic

Cleveland County District Judge Thad Balkman released a decision last Monday declaring Johnson & Johnson and its subsidiary Janssen Pharmaceuticals played a punishable role in the opioid crisis. He ordered Johnson & Johnson pay more than $572 million based on public nuisance claims to account for “misleading” opioid marketing and promotion practices. His decision determined that these practices compromised the health and safety of thousands of Oklahoma residents and contributed to increased rates of additional and overdose deaths. Johnson & Johnson has already promised to appeal the “highly flawed” judgment.

Continue reading “Health Policy Report (9/3)”